Fundraising Fox
Inditreat
1 known investors
Find your way into Inditreat
Sign up to see every warm intro you have to Inditreat
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inditreat team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IndiTreat is a CE IVD-marked functional drug sensitivity test that uses patient-derived tumor organoids to guide personalized treatment decisions for metastatic colorectal cancer (mCRC) patients. It is aimed at healthcare professionals and oncologists as a complement to traditional biomarker testing.
Investors · 1
Frequently asked questions
- What does Inditreat do?
- IndiTreat is a CE IVD-marked functional drug sensitivity test that uses patient-derived tumor organoids to guide personalized treatment decisions for metastatic colorectal cancer (mCRC) patients. It is aimed at healthcare professionals and oncologists as a complement to traditional biomarker testing.
- Who are Inditreat's investors?
- Inditreat's investors include Kinled Holding.